Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Argentaffinoma

erlotinib hydrochloride has been researched along with Argentaffinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drpa, G; Kukulj, S; Manojlovic, S; Sreter, KB1
Aubry, MC; Rickman, OB; Sanyal, B; Thomas, CF; Vohra, PK; Vrana, JA; Wigle, DA1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Argentaffinoma

ArticleYear
Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?
    Anti-cancer drugs, 2018, Volume: 29, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasms, Multiple Primary; Protein Kinase Inhibitors

2018
Analysis of ErbB receptors in pulmonary carcinoid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Adult; Aged; Base Sequence; Carcinoid Tumor; Cell Proliferation; DNA Mutational Analysis; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Immunoblotting; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Mutation; Phosphorylation; Polymorphism, Single Nucleotide; Quinazolines; ras Proteins; Receptor, ErbB-2; Receptor, ErbB-3; Receptor, ErbB-4; Signal Transduction

2009